February 2007
CIGNA HealthCare UK enhances cancer cover
CIGNA HealthCare will now cover active treatment for primary cancer to include first
line metastases (secondary cancers) which were previously excluded as chronic conditions.
Ann Dougan, CIGNA’s marketing director says:
“In line with the latest thinking on cancer treatment from organisations such as
Cancerbackup and the Association of British Insurers, we believe that the “traditional”
definitions of chronic and acute are no longer suitable.
By enhancing our cover and applying active, supportive and symptomatic definitions
to our cancer treatments, we are providing not only a choice but clear and consistent
information for our clients and intermediaries alike.”
CIGNA is also covering an extended list of evidence based cancer treatments which
are not all available on the NHS. Developed by the CIGNA oncology advisory panel,
this list will be regularly updated and reviewed to incorporate the latest drug
developments.
Dougan continued:
“Basically, we felt that we needed to undertake a comprehensive review of our cancer
cover – this included adopting best practice definitions, providing client choice
and covering evidence based treatments. People are living with cancer and leading
active and productive lives – this is being recognised and healthcare benefits should
reflect this.”
The new CIGNA Oncology ProgrammE (COPE) will also entitle all members to confidential
access to clinical advice and support from experienced “Care Specialist” nurses.
- Ends-
For further information please contact
Nichola Dobricki, CIGNA’s Marketing
Development Executive on 01475 492415, Nichola.dobricki@cigna.com
or the CIGNA press office on 01475 492484.
Notes to Editors:
CIGNA HealthCare is one of the UK’s leading providers of employee health benefits
and services, including: private medical insurance, managed care services, cover
for expatriates, corporate dental plans and absence management and occupational
health services.